A small implantable device using LEDs has been developed to treat bladder problems, with the potential to replace current medications and electronic stimulators.
Find out more about the latest news in cardiovascular research including the development of disease biomarkers and cardiomyocyte sensors in this round-up.
Researchers from McMaster University (Ontario, Canada) have discovered several new biomarkers that could allow earlier detection of cystic fibrosis from a single drop of blood.
A noninvasive skin-stripping test has been developed to differentiate between eczema and psoriasis when diagnosing inflammatory skin diseases.
Researchers from Syracuse University (NY, USA) have developed a novel class of nanobiosensor that could detect, characterize and analyze protein–protein interactions in blood serum to assist in cancer detection.
Thermo Fisher Scientific (MA, USA) have announced the launch of a new complementary diagnostic immunoassay, the Thermo Scientific QMS Plazomicin Immunoassay, for measuring the concentration of a novel therapeutic antibiotic, plazomicin, used to treat complicated urinary tract infections.
From the quantification and validation of biomarkers to the integration of novel technology in bioanalytical workflows, as the year comes to a close we’re looking back on the bioanalytical highlights from 2018.
Researchers from the University of Queensland (Australia) have discovered a unique biomarker common to multiple cancers that has the potential to change the way early stage cancer is diagnosed.
Researchers fromat the University of British Columbia Okanagan (Kelowna, Canada) have developed a tool, using biosensors, to provide almost instant diagnosis of bacterial infections.
Collaboration in action: Nepali chemist receives 10 week bioanalytical training at three Dutch CRO’s
A Chemist and Quality Control Manager from a Nepali pharmaceutical company receives full training in bioanalytical method development and validation.